JPRN-UMIN000004819招募中2 期
Phase II trial of trastumab and weekly paclitaxel for breast cancer. -Japan Breast Cancer Research Network (JBCRN) Trial - trastumab and weekly paclitaxel for breast cancer.
Japan Breast Cancer Research Network (JBCRN)0 个研究点目标入组 25 人开始时间: 2011年2月1日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 发起方
- 入组人数
- 25
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 75years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Patient had already treated with palitaxel or trastumab. 2) anaphyaxy of durg 3) pregnant condition
研究者
相似试验
已完成
不适用
A phase II study of paclitaxel plus trastuzumab in patients with pretreated recurrent or metastatic gastric cancer.advanced gastric cancerJPRN-UMIN000006403Toyama Prefectural Central Hospital30
已完成
2 期
Phase II study of trastuzumab and paclitaxel in patients with HER2 positive (IHC 3+, IHC 2+ and FISH +) previously treated advanced or recurrent gastric cancerHER2 positive advanced or recurrent gastric cancerJPRN-UMIN000006223Japanese Foundation for Multidisciplinary Treatment of Cancer35
已完成
1 期
Phase I/II study of Paclitaxel+Trastuzumab therapy in 2nd line treatment for advanced or recurrent gastric cancer with HER2 positive.HER2-positive gastric cancerJPRN-UMIN000011863Osaka Medical College Hospital100
已完成
1 期
Phase1/2 study of nab-Paclitaxel + trastuzumab therapy in 2nd line treatment for HER2-positive advanced or recurrent gastric cancer refractory to trastuzumab combined with fluoropyrimidine and platinum.HER2-positive gastric cancerJPRN-UMIN000014873Kyoto Prefectural University of Medicine, Gatroenterology and Hepatology23
已完成
2 期
Phase II trial of Trastuzumab in combination with Abraxane for patients with HER2-positive metastatic breast cancerHER2-positive Metastatic breast cancerJPRN-UMIN000006159Kumamoto Breast Cancer Cooperative Group23